Inventor · disambiguated record
Stepan Vyskocil
Also filed as: VYSKOCIL STEPAN
21 granted patents·24 pending applications·131 citations·filing 2007–2024
94Inventor score
Files withMILLENNIUM PHARM INC15REMIX THERAPEUTICS INC11HIROSE MASAAKI3LANGSTON STEVEN P3TAKEDA PHARMACEUTICALS CO3
Top patents by PatentIndex Score
45 records- 0197US8008307B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2007·Granted Aug 30, 2011·25 cites·17 claims
- 0295US8481550B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesCLAIBORNE CHRISTOPHER F·Filed 2011·Granted Jul 9, 2013·19 cites·14 claims
- 0394US9150525B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2014·Granted Oct 6, 2015·10 cites·19 claims
- 0493US8901136B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·12 cites·9 claims
- 0592US8207177B2Inhibitors of E1 activating enzymesLANGSTON STEVEN P·Filed 2007·Granted Jun 26, 2012·26 cites·9 claims
- 0688US9458108B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2015·Granted Oct 4, 2016·3 cites·18 claims
- 0783US8440664B2Heteroaryls and uses thereofCARDIN DAVID P·Filed 2012·Granted May 14, 2013·9 cites·5 claims
- 0879US11542293B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 3, 2023·1 cites·23 claims
- 0979US8183240B2Heteroaryls and uses thereofCARDIN DAVID P·Filed 2009·Granted May 22, 2012·5 cites·12 claims
- 1078US8796268B2Heteroaryls and uses thereofFREEZE BRIAN S·Filed 2011·Granted Aug 5, 2014·4 cites·30 claims
- 1178US8796271B2Heteroaryls and uses thereofHIROSE MASAAKI·Filed 2011·Granted Aug 5, 2014·4 cites·48 claims
- 1276US2025262298A1Sting modulator compounds with sulfamate linkages, and methods of making and usingCIAVARRI JEFFREY·Filed 2024·Application pending·0 cites
- 1375US10144742B2Quinoxaline compounds and uses thereofMILLENNIUM PHARM INC·Filed 2015·Granted Dec 4, 2018·3 cites·17 claims
- 1474US8765746B2Heteroaryls and uses thereofFREEZE BRIAN S·Filed 2011·Granted Jul 1, 2014·4 cites·27 claims
- 1570US12054512B2Sting modulator compounds, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Aug 6, 2024·0 cites·23 claims
- 1670US9187482B2Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamateARMITAGE IAN G·Filed 2010·Granted Nov 17, 2015·3 cites·29 claims
- 1769US9139589B2Heteroaryls and uses thereofHIROSE MASAAKI·Filed 2010·Granted Sep 22, 2015·2 cites·28 claims
- 1868US10016427B2Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamateMILLENNIUM PHARM INC·Filed 2015·Granted Jul 10, 2018·1 cites·23 claims
- 1967US9718788B2Heteroaryl compounds useful as inhibitors of E1 activating enzymesMILLENNIUM PHARM INC·Filed 2016·Granted Aug 1, 2017·0 cites·1 claims
- 2066US2019255052A1Inhibitors of E1 Activating EnzymesMILLENNIUM PHARM INC·Filed 2018·Application pending·0 cites
- 2162US2013289037A1Inhibitors of e1 activting enzymesMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 2261US2021015915A1Sting modulator compounds with sulfamate linkages, and methods of making and usingTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 2361US2015175563A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2460US2025109140A15-[5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPUTICS INC·Filed 2023·Application pending·0 cites
- 2560US2015175593A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 2660US2017136024A1Inhibitors of e1 activating enzymesMILLENNIUM PHARM INC·Filed 2016·Application pending·0 cites
- 2759US2025082633A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2859US2025326748A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2959US2025092065A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treatment of proliferative diseasesREMIX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3058US2024366612A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3158US2025332173A1Compounds and methods for modulating nucleic acid splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3257US2024409536A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3357US2012258927A1Inhibitors of e1 activating enzymesLANGSTON STEVEN P·Filed 2012·Application pending·0 cites
- 3457US2024368163A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3557US2025333397A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3657US2013165457A9Inhibitors of e1 activating enzymesLANGSTON STEVEN P·Filed 2012·Application pending·0 cites
- 3757US2025154169A1Compounds and methods for modulating splicingREMIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3852US2024239811A15-(5-(piperidin-4-yl)thieno[3,2-c]pyrazol-2-yl]indazole derivatives and related compounds as modulators for splicing nucleic acids and for the tREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3952US2013217689A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 4052US2024002375A12-(indazol-5-yl)-6-(piperidin-4-yl)-1,7-naphthyridine derivatives and related compounds as modulators for splicing nucleic acids and for the treREMIX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4150US2015148334A1Heteroaryls and uses thereofMILLENNIUM PHARM INC·Filed 2014·Application pending·0 cites
- 4248US2022409734A1Antibody drug conjugatesNISHIMOTO YUTAKA·Filed 2020·Application pending·0 cites
- 4337US9062038B2Heteroaryls and uses thereofHIROSE MASAAKI·Filed 2011·Granted Jun 23, 2015·0 cites·13 claims
- 4435US10323018B2Quinazoline and quinoline compounds and uses thereofMILLENNIUM PHARM INC·Filed 2016·Granted Jun 18, 2019·0 cites·23 claims
- 4533US8796314B2Heteroaryls and uses thereofSHI ZHAN·Filed 2010·Granted Aug 5, 2014·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →